The quality of orthopedic care may be compromised by increasing administrative burdens and payer scrutiny.
The administrative demands of a changing care environment, including correspondence with payers, reviews of advanced imaging and surgery by medical directors and peers, as well as the upkeep of medical records and quality measurements consume increasing amounts of an orthopedist’s time. These added administrative burdens affect the profitability of orthopedic practices to the point where orthopedists are losing the ability to practice freely in a private setting.
While payer scrutiny predominantly affects the surgical component of orthopedic care, the resulting overall economic pressure can also affect pharmacologic treatments of orthopedic conditions such as, pain relief, control of muscle spasms, osteoporosis treatment, and pain-related depression.
PDI can help with pharmaceutical sales strategies that are focused on preserving the financial viability and professional independence of orthopedic practices.
Successful pharmaceutical sales strategies for orthopedics must serve orthopedists’ need to maintain their professional independence and secure the financial viability of their practices. PDI’s medical sales representatives are trained to support the needs of an intact doctor-patient relationship, while customer service representatives and managed market specialists can help minimize unreimbursed workload and facilitate interactions with payers. Our contact center offers additional support for orthopedic practices, including help with prior authorizations and reimbursement issues. Finally, our clinical health educators (CHEs) provide patient education on medications, treatment adherence, and quality-of-life issues.
To maintain the economic viability of their practices and decrease the administrative burden by prior approval and review processes, orthopedists require:
- Assistance with streamlining the prior authorization process
- Development of individualized treatment plans for pain management that consider the patient’s potential risks and benefits, side effects, and functional status
- Optimization of hormonal treatments to prevent or reduce loss of bone mass through osteoporosis